The Omicron variant of coronavirus is less likely to cause long COVID than previous variants, according to the first peer-reviewed study of its kind from the United Kingdom.
https://www.pharmalive.com/wp-content/uploads/2022/06/ReutersUKstudy6-17-2022.jpg8201200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-06-17 02:17:132022-06-17 11:17:41Omicron less likely to cause long COVID, UK study says